Selective Subarachnoid Anesthesia. Comparison of Hyperbaric Bupivacaine and Hyperbaric Prilocaine (BUPIPRILO-07)

August 9, 2013 updated by: Dr. Pere Roura-Poch

Selective Subarachnoid Anesthesia. Comparison of Hyperbaric Bupivacaine and Hyperbaric Prilocaine in Knee Arthroscopy and Inguinal Hernia Repair in Ambulatory Surgery

Selective spinal anesthesia is widely used for ambulatory surgery. Unilateral spinal anesthesia is a suitable option for ambulatory anesthesia as it is efficient and effective. Lidocaine has been the well-known choice for this procedure. However, it is associated to transient neurologic symptoms (TNS). Different anesthetic strategies for this procedure have been performed, for example, the use of small doses of long-acting agents and the use of additives such as opioids. The ideal local anesthetic should be lidocaine-like without risk of transient neurologic symptoms. We design and plan a randomised clinical trial to show if hyperbaric prilocaine 2% would be an alternative.

Study Overview

Study Type

Interventional

Enrollment (Actual)

119

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Catalonia
      • Vic, Catalonia, Spain, 08500
        • Vic Hospital Consortium

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with a scheduled knee arthroscopy
  • Patients with a scheduled inguinal hernioplasty

Exclusion Criteria:

  • Patient refusal to regional anesthesia
  • American Society of Anesthesiologists score risk equal or greater than 4
  • Body mass index greater than 32
  • Coagulopathy
  • Cutaneous infection at injection site

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hyperbaric prilocaine 1%
Solution for injection. Intradural use. In order to obtain Prilocaine 1% we charge a syringe with 2 mL Prilocaine 2%, and we add 1 mL Saline solution (0.9%) and 1 mL Glucose solution (33%). Administer 3 mL of syringe contains in two minutes.
Selective spinal anesthesia was performed on induction-block area and patient was transferred to the assigned operating room where another anesthesiologist (blinded for the arm) began to evaluate the blocking. Neither the nurse, surgeon nor the anesthesiologist involved in the patient evaluation knew the allocation group.
Active Comparator: Hyperbaric Bupivacaine 0.5%
Solution for injection. Intradural use. Charge a syringe with 1 mL of Bupivacaine (0.5%) and administer it in a minute.
Selective spinal anesthesia was performed on induction-block area and patient was transferred to the assigned operating room where another anesthesiologist (blinded for the arm) began to evaluate the blocking. Neither the nurse, surgeon nor the anesthesiologist involved in the patient evaluation knew the allocation group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of stay in post-operative care unit (in minutes)
Time Frame: Participants will be followed an average of 6 hours from surgical incision closure to accomplish discharge criteria to go home
Time in minutes from closing the surgical incision until to having criteria for discharge to home.
Participants will be followed an average of 6 hours from surgical incision closure to accomplish discharge criteria to go home

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of motor blocking
Time Frame: At surgical incision and at 60 minutes after anesthesia
Assessed by Bromage score who ranges from Complete block (unable to move feet or knees, score 1) to Able to perform partial knee bend (score 6 who means nil block).
At surgical incision and at 60 minutes after anesthesia
Fast-track (by-pass recovery area)
Time Frame: Participants will be assessed when surgical incision is closed with surgical staples
Number (and percentage) of patients in each arm that can be transferred directly from the operating room to postsurgical ward. A minimal score of 12 (on modified Aldrete's scoring system with no score <1 in any individual category) would be required for a patient to be fast-tracked.
Participants will be assessed when surgical incision is closed with surgical staples
Peak sensory block level
Time Frame: One minute before surgical incision
The sensory block level was determined pricking dermatomes with a pin from down to up.
One minute before surgical incision
Transient neurological symptoms
Time Frame: At hospital discharge (an average of 8 hours after admission), and at home at 24, 48 and 72 hours after surgery
Researchers surveyed if appears pain originated in gluteal region and radiating to both lower extremities following patients by phone.
At hospital discharge (an average of 8 hours after admission), and at home at 24, 48 and 72 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jordi Serrat-Puyol, MD, Vic Hospital Consortium
  • Study Chair: Pere Roura-Poch, MD, MPH, Vic Hospital Consortium

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2007

Primary Completion (Actual)

May 1, 2007

Study Completion (Actual)

December 1, 2007

Study Registration Dates

First Submitted

August 1, 2013

First Submitted That Met QC Criteria

August 9, 2013

First Posted (Estimate)

August 13, 2013

Study Record Updates

Last Update Posted (Estimate)

August 13, 2013

Last Update Submitted That Met QC Criteria

August 9, 2013

Last Verified

August 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Arthroscopy (for Diagnostic or Therapy)

Clinical Trials on Hyperbaric Prilocaine 1%

Subscribe